Morning Research: VIVUS Inc., Sanofi, DENTSPLY Intl. Inc., and Acura Pharma
LONDON, November 6, 2013
LONDON, November 6, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
The U.S. equity market closed on a mixed note on Tuesday, November 05, 2013.
The NASDAQ Composite gained 0.08%, while the S&P 500 and the Dow Jones
Industrial Average fell by 0.28% and 0.13%, respectively. Shares in the
healthcare sector mostly ended on lower note, even as the broader market
traded between gains and losses. The major movers in the sector included Vivus
Inc. (NASDAQ: VVUS), Sanofi (NYSE: SNY), DENTSPLY International Inc. (NASDAQ:
XRAY), and Acura Pharmaceuticals Inc. (NASDAQ: ACUR). AAAResearchReports.com
has released full comprehensive research on VVUS, SNY, XRAY, and ACUR. These
free technical analyses can be downloaded by signing up at:
Vivus Inc.'s stock declined on Tuesday, even as the broader market ended on a
mixed note. The company's shares traded between $9.36 and $9.58 before ending
the day 1.47% lower at $9.41. A total of 1.29 million shares were traded,
which is below the daily average volume of 2.49 million. Despite Tuesday's
decline, the company's shares have gained 0.21% in the previous three trading
sessions, compared to a gain of 0.37% in the S&P 500 during the same period.
Moreover, Vivus Inc.'s stock is trading below its 50-day and 200-day moving
averages of $10.38 and $12.19, respectively. Download free report on VVUS upon
On Tuesday, Sanofi's stock edged lower to end the day at $52.75, down 0.25%
from the previous day's closing price of $52.88. The company's shares
vacillated between $52.16 and $52.79 during the trading session. A total of
1.36 million shares were traded, which is below the daily average volume of
2.04 million. Despite Tuesday's losses, the company's shares have gained 4.46%
in the last one month and 3.39% in the previous three months, outperforming
the S&P 500, which has gained 4.29% and 3.27% during the respective periods.
Additionally Sanofi's stock is trading above its 50-day and 200-day moving
averages of $50.12 and $51.12, respectively. SNY technical report can be
accessed for free by signing up at:
Shares in DENTSPLY International Inc. ended the day 0.65% lower at $47.14,
after oscillating between $46.98 and $47.44. A total of 0.54 million shares
were traded, which is below the daily average volume of 0.78 million. Despite
Tuesday's pullback, the company's shares have gained 5.96% in the last one
month and 10.40% in the previous three months, outperforming the S&P 500,
which has gained 4.29% and 3.27% during the respective periods. Furthermore,
DENTSPLY International Inc.'s stock is trading near its 52-week high of $47.48
and above its 50-day and 200-day moving averages of $44.20 and $42.52,
respectively. The free report on XRAY can be downloaded by signing up now at:
On Tuesday, Acura Pharmaceuticals Inc.'s stock edged higher to end the day at
$1.75, which is 0.87% higher than the previous day's closing price of $1.73.
The company's shares fluctuated between $1.73 and $1.88 during the trading
session. A total of 0.53 million shares were traded, which is above the daily
average volume of 0.44 million. The company's shares have gained 2.65% in the
previous three trading sessions and 2.05% in the last one month, compared to a
gain of 0.37% and 4.29% in the S&P 500 during the respective periods.
Furthermore, Acura Pharmaceuticals Inc.'s stock is trading above its 50-day
moving average of $1.66. A free report on ACUR can be accessed by registering
1.This is not company news. We are an independent source and our views do
not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
only human and are prone to making mistakes. If you notice any errors or
omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
increase awareness for mentioned companies to our subscriber base and the
4.If you wish to have your company covered in more detail by our team, or
wish to learn more about our services, please contact us at
5.For any urgent concerns or inquiries, please contact us at
6.Are you a public company? Would you like to see similar coverage on your
company? Send us a full investors' package to
research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
SOURCE AAA Research Reports
Contact: Contact Name: Peter F. Jones - Phone #: +1(646)396-9126, Email ID:
Press spacebar to pause and continue. Press esc to stop.